Total Funding
49
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
193240
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Jeff Karp: Co-Founder & Co-chair of Scientific Advisory Board
Michael Jirousek: Chief Operating OfficerPast Role: Astria Therapeutics, Co-Founder & CSO
About the Company
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering.
It was founded in 2015 and headquartered in Woburn, Massachusetts.
